Literature DB >> 12396542

Alternative therapy use in HIV-infected patients receiving highly active antiretroviral therapy.

Kathleen J Risa1, Lisa Nepon, Janice C Justis, Anand Panwalker, Stephen M Berman, Sandro Cinti, Marilyn M Wagener, Nina Singh.   

Abstract

The extent of use of alternative therapies, psychosocial and disease-specific variables predictive of alternative therapy use, and factors motivating the use of alternative therapies in HIV-infected patients receiving highly active antiretroviral therapy (HAART) have not been well defined. Types of alternative therapies used, demographic and medical data, coping (Billing and Moos inventory of coping with illness styles), social support (Irwing and Sarason questionnaire), sense of personal control (Pearlin's Mastery scale), quality of life (Medical Outcome Study scale), health beliefs, and adherence rate were prospectively assessed in 118 HIV-infected patients receiving HAART. Of 38% (45/118) of the patients who used alternative therapies, 56% (25/45) began using alternative therapies since the initiation of HAART. While Caucasian patients were more likely to use alternative therapies than all other patients (P = 0.015), new users of alternative therapies were more likely to be African-American (P = 0.022). Alternative therapy users reported less satisfaction with their emotional support (P = 0.027), and had greater psychological distress (P = 0.048), but were more likely to utilize problem-focused coping (P = 0.015). Patients who used alternative therapies were less likely to believe that HAART was beneficial (P = 0.06). Physicians were unaware of patients' alternative therapy use in 40% (18/45) of all patients who used alternative therapies, in 67% of herbal therapy users, and in 100% of dietary supplement users. Adherence to antiretroviral therapy, CD4 count, and HIV-RNA level were neither predictive nor affected by alternative therapy use. Despite scepticism about the benefits of HAART, resort to alternative therapies did not undermine adherence with antiretroviral therapy. Although able actively to cope with their illness, users of alternative therapies had greater psychological distress and were less satisfied with their emotional support. Interventions aimed at promoting their psychological well-being and enhancing the emotional support should be considered in these patients.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12396542     DOI: 10.1258/095646202760326471

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


  9 in total

Review 1.  A systematic review of the prevalence of herb usage among racial/ethnic minorities in the United States.

Authors:  Paula Gardiner; Julia Whelan; Laura F White; Amanda C Filippelli; Nazleen Bharmal; Ted J Kaptchuk
Journal:  J Immigr Minor Health       Date:  2013-08

Review 2.  A review of the use of complementary and alternative medicine and HIV: issues for patient care.

Authors:  Ava Lorenc; Nicola Robinson
Journal:  AIDS Patient Care STDS       Date:  2013-09       Impact factor: 5.078

Review 3.  Drug interactions with antiretrovirals.

Authors:  Linda M Catanzaro; Judianne C Slish; Robert DiCenzo; Gene D Morse
Journal:  Curr HIV/AIDS Rep       Date:  2004-06       Impact factor: 5.071

Review 4.  Complementary and alternative medicine use among HIV-positive people: research synthesis and implications for HIV care.

Authors:  Rae A Littlewood; Peter A Vanable
Journal:  AIDS Care       Date:  2008-09

5.  Effect of milk thistle on the pharmacokinetics of darunavir-ritonavir in HIV-infected patients.

Authors:  José Moltó; Marta Valle; Cristina Miranda; Samandhy Cedeño; Eugenia Negredo; Bonaventura Clotet
Journal:  Antimicrob Agents Chemother       Date:  2012-03-19       Impact factor: 5.191

6.  Prevalence and predictors of traditional medicine utilization among persons living with AIDS (PLWA) on antiretroviral (ARV) and prophylaxis treatment in both rural and urban areas in South Africa.

Authors:  G D Hughes; T R Puoane; B L Clark; T L Wondwossen; Q Johnson; W Folk
Journal:  Afr J Tradit Complement Altern Med       Date:  2012-07-01

7.  Herb-drug interaction between Echinacea purpurea and etravirine in HIV-infected patients.

Authors:  José Moltó; Marta Valle; Cristina Miranda; Samandhy Cedeño; Eugenia Negredo; Bonaventura Clotet
Journal:  Antimicrob Agents Chemother       Date:  2012-08-06       Impact factor: 5.191

8.  Prevalence and predictors of complementary and alternative medicine use in African-Americans with acquired immune deficiency syndrome.

Authors:  Ashli Owen-Smith; Frances McCarty; Dana Hankerson-Dyson; Ralph Diclemente
Journal:  Focus Altern Complement Ther       Date:  2012-02-16

9.  S-adenosylmethionine (SAM-e) for the treatment of depression in people living with HIV/AIDS.

Authors:  R Andrew Shippy; Douglas Mendez; Kristina Jones; Irene Cergnul; Stephen E Karpiak
Journal:  BMC Psychiatry       Date:  2004-11-11       Impact factor: 3.630

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.